HHS Releases List of 10 Drugs for Medicare Price Negotiations Starting 2026
The Department of Health and Human Services (HHS) in the US has released a list...
Policy / Regulatory
China’s 9th National VBP Tender Round Targets CNS Drugs and Includes Oncology Therapies
The National Allied Procurement Office has released a notification initiating the information filing process for...
NMPA Revises Drug Conditional Approval Procedures: Streamlined Processes and Requirements
The National Medical Products Administration (NMPA) has released the “Drug Conditional Approval Filing Review and...
AstraZeneca Challenges US Government’s Drug Price Negotiation Plan for Medicare
UK-based pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) has filed a legal claim against the US...
CDE Seeks Public Feedback on Biological Product Changes During Clinical Trials
The Center for Drug Evaluation (CDE) is once again seeking public feedback on two key...
CSRC Aims to Rebalance Primary and Secondary Markets with New Regulatory Measures
The China Securities Regulatory Commission (CSRC) has released a document with the aim of “rebalancing”...
China Releases Third List of Pediatric Drugs to Guide Development and Filings
The National Health Commission (NHC), National Healthcare Security Administration, National Medical Products Administration (NMPA), and...
NMPA Releases 72nd Batch of Reference Drugs for GQCE
The National Medical Products Administration (NMPA) has released the 72nd batch of reference drugs for...
Beijing Drafts Regulations for Internet Diagnosis and Treatment, Prohibits AI Prescriptions
The Beijing Municipal Health Commission has released the “Implementation Measures for Internet Diagnosis and Treatment...
CCDI Cartoon Exposes “Prescription Data Rebates” Corruption in China’s Healthcare System
China’s Central Commission for Discipline Inspection (CCDI), the country’s anti-graft bureau, has released a cartoon...
Shanghai Updates Biomedical R&D Import Pilot for Streamlined Customs Clearance
The Shanghai Municipal Commission of Commerce, in collaboration with Shanghai Customs and the Shanghai Municipal...
NHSA Releases Preliminary Review Results for National Reimbursement Drug List Adjustments
The National Healthcare Security Administration (NHSA) has released a notification disclosing the drugs that have...
Henan Leads 19-Province Alliance for Volume-Based Drug Procurement Tender
A new inter-provincial alliance, led by Henan, has formed a 19-strong group to conduct a...
NHC Addresses Anti-Corruption Efforts in Pharmaceutical Industry Nationwide
The National Health Commission (NHC) convened a conference to address questions on the ongoing anti-corruption...
China Unveils State Council Measures to Boost Foreign Direct Investment
The State Council of China has demonstrated its commitment to encouraging greater foreign investment by...
Hunan HSA Implements Direct BMI Fund Payments for VBP-Winning Drugs and Consumables
The Hunan Healthcare Security Administration (HSA) bureau has released a notice stating that effective from...
SAMR and Nine Ministries Tighten Regulations on Forums and Conferences in China
The State Administration for Market Regulation (SAMR) of China, in conjunction with nine other ministries,...
Audit Reveals Illicit Payments and Inflated Prices in Pharmaceutical Industry
An audit has shed light on the use of third-party business promotion companies as a...
Shanghai Health Commission Issues Regulations to Curb Unhealthy Pharmaceutical Practices
In alignment with the No. 75 Document by the National Health Commission, the Shanghai...
National Health Commission Unveils 10 Measures to Enhance Primary Healthcare Services
The National Health Commission has issued a Notice outlining “Measures for Grassroots Health and Convenient...